Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance
Reference number: TA161
Published: 27 October 2008
Last updated: 07 February 2018

TA161 Technologies for the primary and secondary prevention of osteoporotic fractures: Appendix B - proposal paper presented to the Institute's Guidance Executive

$TA161 Technologies for the primary and secondary prevention of osteoporotic fractures: Appendix B - proposal paper presented to the Institute's Guidance Executive$

TA161 Technologies for the primary and secondary prevention of osteoporotic fractures: Appendix B - proposal paper presented to the Institute's Guidance Executive
27 August 2013
(1.02 Mb 3 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 23 August 2013